The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access.

Autor: Terstappen J; Department of Paediatric Infectious Disease & Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands., Hak SF; Department of Paediatric Infectious Disease & Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands., Bhan A; Yenepoya Medical College & Centre for Ethics, Yenepoya University, Mangalore, India., Bogaert D; Paediatric Medicine, University of Edinburgh, Edinburgh, UK., Bont LJ; Department of Paediatric Infectious Disease & Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands; ReSViNET Foundation, Zeist, Netherlands., Buchholz UJ; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Clark AD; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK., Cohen C; Center for Respiratory Diseases and Meningitis, University of the Witwatersrand and National Institute for Communicable Diseases, Johannesburg, South Africa., Dagan R; The Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheba, Israel., Feikin DR; Department of Immunization, Vaccines, and Biologicals, WHO, Geneva, Switzerland., Graham BS; Department of Microbiology, Biochemistry & Immunology, Morehouse School of Medicine, Atlanta, GA, USA., Gupta A; Global Immunization, Sabin Vaccine Institute, Washington, DC, USA., Haldar P; Government of India, Ministry of Health and Family Welfare, Delhi, India., Jalang'o R; National Vaccines and Immunization Program, Ministry of Health, Nairobi, Kenya., Karron RA; Boomberg School of Public Health Department of International Health, Johns Hopkins Bloomberg Baltimore, MD, USA., Kragten L; ReSViNET Foundation, Zeist, Netherlands., Li Y; Centre for Global Health, University of Edinburgh, Edinburgh, UK; School of Public Health, Nanjing Medical University, Nanjing, China., Löwensteyn YN; Department of Paediatric Infectious Disease & Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands., Munywoki PK; Centers for Disease Control and Prevention, Nairobi, Kenya., Njogu R; Department of International Health, Jhpiego, Nairobi, Kenya., Osterhaus A; Center of Infection Medicine and Zoonosis Research, University of Veterinary Medicine, Hannover, Germany., Pollard AJ; Oxford Vaccine Group, Department of Pediatrics, University of Oxford, Oxford, UK., Nazario LR; ReSViNET Foundation, Zeist, Netherlands., Sande C; Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Satav AR; MAHAN Trust Mahatma Gandhi Tribal Hospital, Melghat, India., Srikantiah P; Global Health Division, Bill & Melinda Gates Foundation, Seattle, WA, USA., Stein RT; Pneumologia Pediátrica, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil., Thacker N; International Pediatric Association, Webster Groves, MI, USA; Child Health Foundation, Mumbai, India., Thomas R; ReSViNET Patient Network, East Sussex, UK., Bayona MT; Gavi, The Vaccine Alliance, Geneva, Switzerland., Mazur NI; Department of Paediatric Infectious Disease & Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands. Electronic address: n.i.mazur@umcutrecht.nl.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Sep 23. Date of Electronic Publication: 2024 Sep 23.

Substantial Burden of Nonmedically Attended RSV Infection in Healthy-Term Infants: An International Prospective Birth Cohort Study.

Autor: Hak SF; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht., Venekamp RP; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University., Billard MN; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht., van Houten MA; Department of Pediatrics, Spaarne Gasthuis, Hoofddorp and Haarlem, the Netherlands., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, United Kingdom., Heikkinen T; Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland., Cunningham S; Centre for Inflammation Research, University of Edinburgh., Millar M; Children's Clinical Research Facility, NHS Lothian, Edinburgh, United Kingdom., Martinón-Torres F; Genetics, Vaccines and Infections Research Group, Instituto de Investigación Sanitaria de Santiago, University of Santiago de Compostela, Spain., Dacosta-Urbieta A; Genetics, Vaccines and Infections Research Group, Instituto de Investigación Sanitaria de Santiago, University of Santiago de Compostela, Spain., Bont LJ; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht., Wildenbeest JG; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2024 Mar 01; Vol. 229 (Supplement_1), pp. S40-S50.